Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|November 17, 2009
Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, AustraliaDavid J Templeton, Fengyi Jin, Garrett P Prestage, et al.
Frontiers in Immunology|June 28, 2021
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in WomenKhanyisile Mngomezulu, Gugulethu F Mzobe, Andile Mtshali, et al.
Microorganisms|November 25, 2023
Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell SubsetsWenkosi Perez Qulu, Gugulethu Mzobe, Andile Mtshali, et al.
Plos One|April 25, 2018
Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countriesNigel J Garrett, Farzana Osman, Bhavna Maharaj, et al.
Sexually Transmitted Infections|February 20, 2021
Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African womenNigel Garrett, Andile Mtshali, Farzana Osman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine TrialKwabena Asare, Tsion Andine, Nivashnee Naicker, et al.
BMC Pediatrics|March 1, 2012
A 'snip' in time: what is the best age to circumcise?Brian J Morris, Jake H Waskett, Joya Banerjee, et al.
Frontiers in Immunology|October 1, 2021
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial VaginosisAndile Mtshali, James Emmanuel San, Farzana Osman, et al.
Clinical and Vaccine Immunology : CVI|February 6, 2015
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trialDan Apter, Cosette M Wheeler, Jorma Paavonen, et al.
The Lancet. Oncology|November 15, 2011
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialMatti Lehtinen, Jorma Paavonen, Cosette M Wheeler, et al.
Pageof 5